EMA Authorised: Entecavir Viatris (previously Entecavir Mylan) (entecavir monohydrate) — Viatris Limited

View source ↗

Summary

The EMA authorised Entecavir Viatris (entecavir monohydrate) for the treatment of chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entecavir Viatris (entecavir monohydrate)

Snippet

Status: Authorised. Therapeutic area: Hepatitis B. MAH: Viatris Limited. Decision date: 15/01/2026